Behzad Rowshanravan

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Alan Kennedy, Erin Waters, Behzad Rowshanravan et al. · Nature Immunology · 2022 · 212 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations

Tie Zheng Hou, Nisha Verma, Jennifer Wanders et al. · Blood · 2017 · 100 citations · Full text

Life Sciences, Genetics, Immunology +16

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4

Neil Halliday, Cayman Williams, Alan Kennedy et al. · Frontiers in Immunology · 2020 · 92 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The in vitro characterization of a gelatin scaffold, prepared by cryogelation and assessed in vivo as a dermal replacement in wound repair

Rostislav V. Shevchenko, Marc Eeman, Behzad Rowshanravan et al. · Acta Biomaterialia · 2014 · 56 citations

Engineering, Bioengineering, Biomedical Engineering +17

Characterization of CTLA4 Trafficking and Implications for Its Function

Sahamoddin Khailaie, Behzad Rowshanravan, Philippe A. Robert et al. · Biophysical Journal · 2018 · 55 citations · Full text

Life Sciences, Immunology, Molecular Biology +12